Catherine Moukheibir - 15 Mar 2022 Form 4 Insider Report for IRONWOOD PHARMACEUTICALS INC (IRWD)

Role
Director
Signature
/s/ Brian Tessler, Attorney-in-Fact
Issuer symbol
IRWD
Transactions as of
15 Mar 2022
Net transactions value
$0
Form type
4
Filing time
17 Mar 2022, 16:05:26 UTC
Previous filing
17 Dec 2021
Next filing
15 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IRWD Class A Common Stock Award $0 +1,466 +1.9% $0.000000 77,779 15 Mar 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued pursuant to the Director Compensation Policy, effective May 2019.

Remarks:

Exhibit 24 - Power of Attorney